RXRX · Recursion Pharmaceuticals, Inc. · Investor Relations
$3.70
+0.12 (+3.35%)
At close · Oct 23
Return incl. dividend (before tax)
Market Cap
$1.98B
Shares
535.34M
Volume · Oct 23
19.08M
Avg daily vol (3M)
21.75M
Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2026-09-15 | Morgan Stanley 24th Annual Global Healthcare Conference | Conference |
| 2026-08-11 | Bank of America 2026 SMID Cap Executive Insights Event | Event |
| 2026-08-05 | Recursion 2Q 2026 Earnings Call | Earnings call |
| 2026-08-05 | Q2 Earnings conference call (announced in 8-K) | Earnings call |
| 2026-06-17 | 2026 Annual Meeting of Stockholders | Shareholder meeting |
| 2026-06-09 | Goldman Sachs 47th Annual Global Healthcare Conference | Conference |
| 2026-05-12 | Bank of America Health Care Conference 2026 | Conference |
| 2026-05-06 | Q1 Earnings conference call (announced in 8-K) | Earnings call |
| 2026-02-25 | Earnings conference call (announced in 8-K) | Earnings call |
Source: https://ir.recursion.com/
Key facts
CIK
1601830
CUSIP
75629V104
13F (30d)
51 filings
51 filers
Visit website
Investor relations